• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

早期乳腺癌的血血红蛋白水平与治疗结果

Blood hemoglobin level and treatment outcome of early breast cancer.

作者信息

Henke Michael, Sindlinger Florian, Ikenberg Hans, Gerds Thomas, Schumacher Martin

机构信息

Department of Radiotherapy, Radiological University Clinic, University Freiburg, Germany.

出版信息

Strahlenther Onkol. 2004 Jan;180(1):45-51. doi: 10.1007/s00066-004-1123-7.

DOI:10.1007/s00066-004-1123-7
PMID:14704844
Abstract

BACKGROUND AND PURPOSE

To determine whether the blood hemoglobin concentration correlates with the prognosis of patients with early breast cancer and, if so, whether this is restricted to treatment modality.

PATIENTS AND METHODS

Data were collected retrospectively from patients with early breast cancer (T1,2 N0-2 M0) who underwent either breast-conserving surgery followed by adjuvant radiotherapy (BCS-RT; n=96) or a modified radical mastectomy (MRM; n=194). The effect of preoperative blood hemoglobin level, nodal status, histological grading and hormone receptor status on disease-free survival was determined for both treatment modalities using a Cox regression model and visualized by Kaplan-Meier plots.

RESULTS

The blood hemoglobin concentration significantly correlated with disease-free survival of patients receiving BCS-RT (relative risk [RR]: 0.67 per g/dl; p=0.007). This was independent of other known risk factors for breast cancer patients, as determined by multivariate analysis. By contrast, the blood hemoglobin level had no prognostic significance when patients were treated with MRM.

CONCLUSION

Blood hemoglobin concentration seems to affect the prognosis of patients with early breast cancer when a treatment schedule that includes radiotherapy is applied. Reduced radiosensitivity due to diminished tumor oxygenation may be the underlying cause. Confirmative trials and studies intended to elucidate the underlying mechanism are warranted.

摘要

背景与目的

确定血血红蛋白浓度是否与早期乳腺癌患者的预后相关,若相关,这种相关性是否仅限于治疗方式。

患者与方法

回顾性收集早期乳腺癌(T1,2 N0 - 2 M0)患者的数据,这些患者接受了保乳手术加辅助放疗(BCS - RT;n = 96)或改良根治性乳房切除术(MRM;n = 194)。使用Cox回归模型确定术前血血红蛋白水平、淋巴结状态、组织学分级和激素受体状态对两种治疗方式无病生存期的影响,并通过Kaplan - Meier曲线进行可视化展示。

结果

血血红蛋白浓度与接受BCS - RT治疗患者的无病生存期显著相关(相对风险[RR]:每克/分升为0.67;p = 0.007)。多因素分析表明,这与乳腺癌患者的其他已知风险因素无关。相比之下,接受MRM治疗的患者,血血红蛋白水平无预后意义。

结论

当应用包括放疗的治疗方案时,血血红蛋白浓度似乎会影响早期乳腺癌患者的预后。肿瘤氧合减少导致的放射敏感性降低可能是其潜在原因。有必要进行验证性试验和旨在阐明潜在机制的研究。

相似文献

1
Blood hemoglobin level and treatment outcome of early breast cancer.早期乳腺癌的血血红蛋白水平与治疗结果
Strahlenther Onkol. 2004 Jan;180(1):45-51. doi: 10.1007/s00066-004-1123-7.
2
[Local relapse in young (< or = 40 years) women with breast cancer after mastectomy or breast conserving surgery: 15-year results].[40岁及以下年轻女性乳腺癌乳房切除或保乳手术后的局部复发:15年结果]
Magy Onkol. 2005;49(3):203, 205-8. Epub 2005 Oct 25.
3
Patients with t1 to t2 breast cancer with one to three positive nodes have higher local and regional recurrence risks compared with node-negative patients after breast-conserving surgery and whole-breast radiotherapy.与保乳手术和全乳放疗后的无淋巴结转移患者相比,有1至3个阳性淋巴结的T1至T2期乳腺癌患者有更高的局部和区域复发风险。
Int J Radiat Oncol Biol Phys. 2009 Feb 1;73(2):357-64. doi: 10.1016/j.ijrobp.2008.04.034.
4
Prognostic significance of bcl-2 expression in stage III breast cancer patients who had received doxorubicin and cyclophosphamide followed by paclitaxel as adjuvant chemotherapy.在接受多柔比星和环磷酰胺序贯紫杉醇辅助化疗的III期乳腺癌患者中,bcl-2表达的预后意义
BMC Cancer. 2007 Apr 12;7:63. doi: 10.1186/1471-2407-7-63.
5
Cyclin-E is a strong predictor of endocrine therapy failure in human breast cancer.细胞周期蛋白E是人类乳腺癌内分泌治疗失败的一个强有力预测指标。
Oncogene. 2003 Jul 31;22(31):4898-904. doi: 10.1038/sj.onc.1206818.
6
[The prognostic value of cathepsin D concentration in cytosol of primary breast carcinoma].[组织蛋白酶D浓度在原发性乳腺癌细胞溶质中的预后价值]
Zentralbl Gynakol. 1995;117(5):253-9.
7
Estrogen-dependent prognostic significance of cyclooxygenase-2 expression in early-stage invasive breast cancers treated with breast-conserving surgery and radiation.在接受保乳手术和放疗的早期浸润性乳腺癌中,环氧合酶-2表达的雌激素依赖性预后意义。
Int J Radiat Oncol Biol Phys. 2008 Jul 15;71(4):1006-13. doi: 10.1016/j.ijrobp.2007.11.063. Epub 2008 Feb 11.
8
Predictive value of estrogen receptor status as assessed by ligand-binding assay in patients with early-stage breast cancer treated with breast conserving surgery and radiation therapy.通过配体结合试验评估雌激素受体状态在接受保乳手术和放射治疗的早期乳腺癌患者中的预测价值。
Oncol Rep. 2002 Mar-Apr;9(2):375-8.
9
Influence of the time between surgery and radiotherapy on local recurrence in patients with lymph node-positive, early-stage, invasive breast carcinoma undergoing breast-conserving surgery: results of the French Adjuvant Study Group.手术与放疗间隔时间对接受保乳手术的淋巴结阳性早期浸润性乳腺癌患者局部复发的影响:法国辅助治疗研究组的结果
Cancer. 2005 Jul 15;104(2):240-50. doi: 10.1002/cncr.21161.
10
Treatment results and prognostic factors of early breast cancer treated with a breast conserving operation and radiotherapy.保乳手术联合放疗治疗早期乳腺癌的治疗结果及预后因素
Jpn J Clin Oncol. 2005 Mar;35(3):126-33. doi: 10.1093/jjco/hyi039.

引用本文的文献

1
Prophylactic red blood cell transfusions in children and neonates with cancer: An evidence-based clinical practice guideline.儿童和新生儿癌症患者的预防性红细胞输血:循证临床实践指南。
Support Care Cancer. 2024 Nov 4;32(11):766. doi: 10.1007/s00520-024-08888-3.
2
A nomogram based on inflammation and nutritional biomarkers for predicting the survival of breast cancer patients.基于炎症和营养生物标志物的列线图预测乳腺癌患者的生存情况。
Front Endocrinol (Lausanne). 2024 Aug 7;15:1388861. doi: 10.3389/fendo.2024.1388861. eCollection 2024.
3
The Importance of Hypoxia-Related to Hemoglobin Concentration in Breast Cancer.
缺氧相关血红蛋白浓度在乳腺癌中的重要性。
Cell Biochem Biophys. 2024 Sep;82(3):1893-1906. doi: 10.1007/s12013-024-01386-7. Epub 2024 Jul 3.
4
Development and Validation of a Nomogram for Predicting Survival Based on Ferritin and Transferrin Ratio in Breast Cancer Patients.基于铁蛋白和转铁蛋白比值的乳腺癌患者生存预测列线图的建立和验证。
Cancer Control. 2024 Jan-Dec;31:10732748241261553. doi: 10.1177/10732748241261553.
5
A practical dynamic nomogram model for predicting bone metastasis in patients with thyroid cancer.用于预测甲状腺癌患者骨转移的实用动态列线图模型。
Front Endocrinol (Lausanne). 2023 Mar 6;14:1142796. doi: 10.3389/fendo.2023.1142796. eCollection 2023.
6
Prevalence of anemia among Saudi patients with solid cancers at diagnosis in King Faisal Hospital, Taif Province, Kingdom of Saudi Arabia.沙特阿拉伯王国塔伊夫省法赫德国王医院确诊的实体癌沙特患者贫血患病率
PLoS One. 2021 Jan 28;16(1):e0246202. doi: 10.1371/journal.pone.0246202. eCollection 2021.
7
Risk factors and their diagnostic values for ocular metastases in invasive ductal carcinoma.浸润性导管癌眼部转移的危险因素及其诊断价值。
Cancer Med. 2021 Feb;10(3):824-832. doi: 10.1002/cam4.3656. Epub 2020 Dec 18.
8
Bone Metastasis Prognostic Factors in Breast Cancer.乳腺癌骨转移的预后因素
Breast Cancer (Auckl). 2019 Feb 22;13:1178223419830978. doi: 10.1177/1178223419830978. eCollection 2019.
9
Serum erythropoietin levels, breast cancer and breast cancer-initiating cells.血清促红细胞生成素水平、乳腺癌与乳腺癌起始细胞。
Breast Cancer Res. 2019 Jan 30;21(1):17. doi: 10.1186/s13058-019-1100-9.
10
Clinical characteristics and risk factors for developing bone metastases in patients with breast cancer.乳腺癌患者发生骨转移的临床特征和危险因素。
Sci Rep. 2017 Sep 12;7(1):11325. doi: 10.1038/s41598-017-11700-4.